| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Institute of Neurology (Drs. Servidei, Spinazzola, Mirabella, de Rosa, Ricci, and Tonali), Catholic University and U.I.L.D.M., Rome; Cattedra di Genetica Umana (Drs. Capon, Semprini, Gennarelli, Sangiuolo, Dallapiccola, and Novelli), Dipartimento di Biopatologia e Diagnostica per Immagini, Università di Roma "Tor Vergata," Rome, Italy; Ospedale CSS (Dr. Dallapiccola), I.R.C.C.S., San Giovanni Rotondo, Italy; and the Human Genome Center (Dr. Mohrenweiser), Lawrence Livermore National Laboratory, Livermore, CA.
Address correspondence and reprint requests to Dr. Serenella Servidei, Institute of Neurology, Catholic University, Policlinico Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy.
OBJECTIVE: To characterize a kindred with a distinctive autosomal dominant neuromuscular disorder.
BACKGROUND: The authors studied a large Italian family affected by a progressive neuromyopathy. Ten individuals over three generations were affected. The disease was characterized by onset from the late teens to early 50s with distal leg weakness and atrophy, development of generalized muscle weakness with distal-to-proximal progression sparing facial and ocular muscles, dysphonia and dysphagia, pes cavus and areflexia, variable clinical expression ranging from subclinical myopathy to severely disabling weakness, and mixed neurogenic and myopathic abnormalities on electromyography.
METHODS: Morphologic, immunocytochemical, and ultrastructural studies were performed in muscle biopsies from three affected patients. A genomewide linkage analysis through the genotyping of 292 microsatellite markers spanning the 22 autosomes was undertaken to map the disorder segregating in this family.
RESULTS: All muscle biopsies showed variation of fiber size, panesterase-positive angular fibers, mild to severe fibrosis, and numerous "rimmed vacuoles." Electron microscopy failed to demonstrate the nuclear or cytoplasmic filamentous inclusions specific of inclusion-body myopathies and, accordingly, immunohistochemistry did not show any positivity with SMI-31 antibodies detecting hyperphosphorylated tau. Preliminary analysis of 292 microsatellite markers provided evidence for linkage to chromosome 19p13.
CONCLUSIONS: This distinctive autosomal dominant disorder is characterized by a vacuolar neuromyopathy. Localization to chromosome 19p13 will allow the genetic relationship between this disease and inherited myopathies with rimmed vacuoles, in particular autosomal dominant inclusion-body myopathies, to be defined.
Key words: Autosomal dominant vacuolar neuromyopathy—Rimmed vacuoles—Linkage.
This article has been cited by other articles:
|
|
 |
|
  I. Mahjneh, H. Haravuori, A. Paetau, L.V.B. Anderson, A. Saarinen, B. Udd, and H. Somer A distinct phenotype of distal myopathy in a large Finnish family Neurology, July 8, 2003; 61(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Marino, J. A. Uria, X. S. Puente, V. Quesada, J. Bordallo, and C. Lopez-Otin Human Autophagins, a Family of Cysteine Proteinases Potentially Implicated in Cell Degradation by Autophagy J. Biol. Chem., January 31, 2003; 278(6): 3671 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Muir, L. Chamberlain, N. A. Elshourbagy, D. Michalovich, D. J. Moore, A. Calamari, P. G. Szekeres, H. M. Sarau, J. K. Chambers, P. Murdock, et al. AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1 J. Biol. Chem., July 27, 2001; 276(31): 28969 - 28975. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
